Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors

Adi F. Gazdar(Southwestern Medical Center)
Oncogene
August 1, 2009
Cited by 985Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis